Medicenna Therapeutics Corp. SEC filings MDNAF
Medicenna Therapeutics Corp. has 178 filings in SEC EDGAR's recent list, going back to Mar 30, 2020. Its latest annual report, Form 20-F, was filed on Jun 27, 2023 for the period ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on May 13, 2024. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | May 10, 2024 | — |
| S-8 POS | Form s-8 pos | Apr 16, 2024 | — |
| F-3/A | Filing | Apr 16, 2024 | — |
| F-10POS | Filing | Apr 16, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 17, 2023 | — |
| S-8 | Employee stock plan registration | Jul 31, 2020 | — |
| F-10/A | Filing | Jul 28, 2020 | — |
| F-X | Form f-x | Jun 3, 2020 | — |
| F-10 | Form f-10 | Jun 3, 2020 | — |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDNAF (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1807983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.